JW Pharmaceutical Corporation (001067.KS) KSC

60,600.00

+0(+0.00%)

Updated at December 05 12:00PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio11.78
PEG Ratio-0.7
Price/Sales Ratio0.82
Price/Book Ratio1.89
Enterprise/Revenue0.93
Enterprise/EBITDA3.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.12

Management Effectiveness

Return On Assets0.09
Return On Equity0.16

Income Statement

Revenue719.38B
Revenue/Share32,012.37
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash72.53B
Total Cash/Share1,508.94
Total Debt90.73B
Total Debt/Equity0.28
Current Ratio1.41
Book Value Per Share13,931.31

Price History

52-Week Change-1.62
52-Week High65,600
52-Week Low56,100
Moving Average 50 Days60,306
Moving Average 200 Days61,212.5

Statistics

Average Volume65
Shares Outstanding9.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield1.71
Payout Ratio0.21
Last Split Factor51:50
Last Split DateDecember 27, 2023